Xarelto (Rivaroxaban) is an anticoagulant first approved by the FDA in July 2011. Since then, Xarelto has been linked to serious, potentially fatal side effects.
Xarelto is a blood thinner manufactured by Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, and is co-marketed by Bayer Healthcare AG. Xarelto is prescribed to patients who suffer from atrial fibrillation, deep vein thrombosis, and pulmonary embolisms. Additionally, Xarelto has also been given to patients who have recently undergone hip or knee replacement surgery. Xarelto is marketed as a safer, more convenient alternative to warfarin, which has been the gold standard since 1954.
To date, there have been over 1,800 adverse incident reports made to the FDA’s Adverse Events Reporting System where Xarelto has been the cause. The most common adverse events reported were pulmonary embolisms, deep vein thrombosis, gastrointestinal hemorrhage, and hemorrhage. Other events reported include thrombosis, hemoglobin decrease, cerebrovascular accidents, hematoma, edema peripheral, and dyspnea. In addition to the adverse events listed above, over 180 patients have lost their lives as a result of Xarelto’s negative side effects.
If you or a loved one has experienced unusual bleeding, stroke, or any other negative side effect as a result of taking Xarelto, it is important that you seek medical and legal advice. The Talaska Law Firm is currently investigating and accepting cases involving Xarelto. The law limits the amount of time you have to protect your rights, so contact us today for a free case evaluation.